secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2025-08-13T23:59:59+00:00
Accession:  0001372514-25-000068
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Kiora Pharmaceuticals furnishes updated investor presentation for H.C. Wainwright conference
--------------------------------------------------------------------------------

- Filed 8-K on August 13, 2025 to disclose updated investor presentation (Exhibit 99.1).
- Presentation prepared for H.C. Wainwright 5th Annual Ophthalmology Virtual Conference.
- Company CFO Melissa Tosca signed the report as principal financial officer.
- Data presented under Item 7.01 Regulation FD and not deemed filed for Exchange Act purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000137251425000068/0001372514-25-000068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000137251425000068/kprx-20250813.htm
  HTML page:      https://secwatch.observer/filing/0001372514-25-000068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer